Video

Ushering in the Golden Era of Alzheimer Drug Development?

Author(s):

RJ Tesi, MD

What effect will aducanumab have on Alzheimer disease treatment?

RJ Tesi, MD, discusses the recent aducanumab FDA approval and the implications it will have on the treatment of Alzheimer disease.

Dr Tesi is CEO and Chief Medical Officer of INmuneBio.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
New Africa /Adobestock
Alzheimer
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
Related Content
GLP 1
July 7th 2025

Transformation 2.0: The GLP-1 RAs as Psychiatric Medications?

Roger S. McIntyre, MD, FRCPC
What Will the Future of Alzheimer Disease Treatment Look Like?
July 23rd 2021

What Will the Future of Alzheimer Disease Treatment Look Like?

Helen Lavretsky, MD, MS
pills
April 30th 2025

April in Review: Updates on the Psychiatric Treatment Pipeline

Leah Kuntz
Site Logo
August 16th 2012

The Relevance of New Alzheimer Guidelines for Clinical Practice

Christopher Van Dyck, MD
cognition
April 14th 2025

Diagnostic Considerations in Clinical Cognitive Assessment

Lisa M. Wise, MD Vimal M. Aga, MD, DFAPA
Alzheimer
April 4th 2025

Positive Interim Results on Trontinemab Validate Brainshuttle Technology for Alzheimer Disease Treatment

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.